Medicare, the federal health insurance program for individuals aged 65 and older, is at a crossroads. With over 54 percent of beneficiaries now enrolled in Medicare Advantage (MA) plans, questions arise about the future of both MA and traditional Medicare. Healthcare policy expert Dr. J. Michael
In an era marked by rapid advancements in medical technology, ensuring the safety and efficacy of medical devices remains paramount. The Food and Drug Administration (FDA) has been working diligently on developing a postmarket surveillance system, driven by a 2012 federal law aimed at reducing the
The U.S. pharmaceutical sector faces a critical juncture. With a heavy reliance on Chinese manufacturing for generic drugs and active pharmaceutical ingredients (APIs), the industry finds itself vulnerable. The BIOSECURE Act aims to address these vulnerabilities by reducing or eliminating
Gender bias in medical research has deep historical roots and continues to impact the health outcomes of women today. By understanding this complex issue, we can appreciate the importance of inclusive research practices and explore the steps needed to create a healthcare system that serves everyone
